General Information of the Cell Line
Cell Line ID
CL000700
Cell Line Name
VCaP
Synonyms
VCAP
Vcap
Vertebral Cancer of the Prostate
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_2235
Tissue Information
Bone
Disease
Prostate carcinoma (NCIt: C4863)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT00897, Eag homolog
Compound ID Compound Name Compound Formula
CP0567397
sodium;5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenolate
   Show/Hide
C13H13N4NaO
 1
1
IC50 = 110 nM
   TI
   LI
   LO
   TS
CP0961996
5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol methanesulfonate
   Show/Hide
C14H18N4O4S
 1
1
IC50 = 130 nM
   TI
   LI
   LO
   TS
CP0966203
(E)-5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol hemioxalate
   Show/Hide
C15H16N4O5
 1
1
IC50 = 150 nM
   TI
   LI
   LO
   TS
CP0954039
5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol ethane-1,2-disulfonate
   Show/Hide
C15H20N4O7S2
 1
1
IC50 = 160 nM
   TI
   LI
   LO
   TS
CP0969072
5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol nitrate
   Show/Hide
C13H15N5O4
 1
1
IC50 = 160 nM
   TI
   LI
   LO
   TS
CP0970228
(E)-5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol benzenesulfonate
   Show/Hide
C19H20N4O4S
 1
1
IC50 = 210 nM
   TI
   LI
   LO
   TS
CP0956172
5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol hemisuccinate
   Show/Hide
C17H20N4O5
 1
1
IC50 = 220 nM
   TI
   LI
   LO
   TS
CP0964077
(E)-5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol hydrochloride
   Show/Hide
C13H15ClN4O
 1
1
IC50 = 220 nM
   TI
   LI
   LO
   TS
CP0576217
5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol
   Show/Hide
C13H14N4O
 1
1
IC50 = 230 nM
   TI
   LI
   LO
   TS
CP0961173
(E)-5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol hydrobromide
   Show/Hide
C13H15BrN4O
 1
1
IC50 = 240 nM
   TI
   LI
   LO
   TS
CP0961995
(E)-5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol 4-methylbenzenesulfonate
   Show/Hide
C20H22N4O4S
 1
1
IC50 = 240 nM
   TI
   LI
   LO
   TS
CP0964593
5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol 2,5-dihydroxybenzoate
   Show/Hide
C20H20N4O5
 1
1
IC50 = 240 nM
   TI
   LI
   LO
   TS
CP0946318
(E)-5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol sulfate
   Show/Hide
C13H16N4O5S
 1
1
IC50 = 260 nM
   TI
   LI
   LO
   TS
CP0967514
5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol maleate
   Show/Hide
C17H18N4O5
 1
1
IC50 = 260 nM
   TI
   LI
   LO
   TS
CP0537350
1-(1,3-thiazol-2-yldiazenyl)naphthalen-2-ol
   Show/Hide
C13H9N3OS
 1
1
IC50 = 310 nM
   TI
   LI
   LO
   TS
CP0569841
5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol;naphthalene-1,5-disulfonic acid
   Show/Hide
C23H22N4O7S2
 1
1
IC50 > 500 nM
   TI
   LI
   LO
   TS
CP0955626
(E)-5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol dinaphthalene-2-sulfonate
   Show/Hide
C23H22N4O4S
 1
1
IC50 > 500 nM
   TI
   LI
   LO
   TS
CP0957115
5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol fumarate
   Show/Hide
C17H18N4O5
 1
1
IC50 > 500 nM
   TI
   LI
   LO
   TS
CP0961994
(E)-5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol 2-hydroxyacetate
   Show/Hide
C15H18N4O4
 1
1
IC50 > 500 nM
   TI
   LI
   LO
   TS
CP0964692
(E)-5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol ethanesulfonate
   Show/Hide
C15H20N4O4S
 1
1
IC50 > 500 nM
   TI
   LI
   LO
   TS
CP0964898
(E)-5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol 2-hydroxysuccinate
   Show/Hide
C17H20N4O6
 1
1
IC50 > 500 nM
   TI
   LI
   LO
   TS
CP0965927
5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol(2R,3R)-2,3-dihydroxysuccinate
   Show/Hide
C17H20N4O7
 1
1
IC50 > 500 nM
   TI
   LI
   LO
   TS
CP0969073
(E)-5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol 2-oxopropanoate
   Show/Hide
C16H18N4O4
 1
1
IC50 > 500 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0037412
(2R)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorobenzene)sulfonyl]-2-hydroxy-2-methylpropanamide
   Show/Hide
C18H14F4N2O4S  2
1
IC50 = 51600 nM
   TI
   LI
   LO
   TS
2
IC50 = 51607 nM
   TI
   LI
   LO
   TS
CP0217093
Enobosarm
   Show/Hide
C19H14F3N3O3  1
1
IC50 = 24470 nM
   TI
   LI
   LO
   TS
CP0410892
2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethyl)phenyl]sulfonylpropanamide
   Show/Hide
C18H14F6N2O6S  1
1
IC50 = 27550 nM
   TI
   LI
   LO
   TS
CP0482916
2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethyl)phenoxy]propanamide
   Show/Hide
C18H14F6N2O5  1
1
IC50 = 27160 nM
   TI
   LI
   LO
   TS
CP0482950
2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-[3-(trifluoromethoxy)phenoxy]propanamide
   Show/Hide
C18H14F6N2O6  1
1
IC50 = 9600 nM
   TI
   LI
   LO
   TS
CP0543070
3-[4-cyano-2-(trifluoromethyl)phenoxy]-N-[4-cyano-2-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
   Show/Hide
C20H13F6N3O3  1
1
IC50 = 17700 nM
   TI
   LI
   LO
   TS
CP0549132
3-chloro-5-[8-oxo-5-(4-piperidin-4-yloxyphenyl)-6-sulfanylidene-5,7-diazaspiro[3.4]octan-7-yl]pyridine-2-carbonitrile
   Show/Hide
C23H22ClN5O2S  1
1
IC50 = 503 nM
   TI
   LI
   LO
   TS
CP0567476
5-[8-oxo-5-(4-piperidin-4-yloxyphenyl)-6-sulfanylidene-5,7-diazaspiro[3.4]octan-7-yl]-3-(trifluoromethyl)pyridine-2-carbonitrile
   Show/Hide
C24H22F3N5O2S  1
1
IC50 = 306 nM
   TI
   LI
   LO
   TS
CP0569841
5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol;naphthalene-1,5-disulfonic acid
   Show/Hide
C23H22N4O7S2  1
1
IC50 > 500 nM
   TI
   LI
   LO
   TS
CP0964692
(E)-5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol ethanesulfonate
   Show/Hide
C15H20N4O4S  1
1
IC50 > 500 nM
   TI
   LI
   LO
   TS
CP0969073
(E)-5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol 2-oxopropanoate
   Show/Hide
C16H18N4O4  1
1
IC50 > 500 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Bone)
Cell Line Name Organism Disease
Raji Homo sapiens (Human) EBV-related Burkitt lymphoma
Cheptage Homo sapiens (Human) EBV-related Burkitt lymphoma
HT-1080 Homo sapiens (Human) Fibrosarcoma
2fTGH-U3A Homo sapiens (Human) Fibrosarcoma
HT1080-luc2 Homo sapiens (Human) Fibrosarcoma
U2OS Homo sapiens (Human) Osteosarcoma
SaOS-2 Homo sapiens (Human) Osteosarcoma
G-292 clone A141B1 Homo sapiens (Human) Osteosarcoma
HOS Homo sapiens (Human) Osteosarcoma
MG-63 Homo sapiens (Human) Osteosarcoma
SJSA-1 Homo sapiens (Human) Osteosarcoma
GHOST(3).CXCR4 Homo sapiens (Human) Osteosarcoma
GHOST(3).CCR5 Homo sapiens (Human) Osteosarcoma
143.98.2 Homo sapiens (Human) Osteosarcoma
GHOST(3).X4/R5 Homo sapiens (Human) Osteosarcoma
PathHunter U2OS DRD3 beta-arrestin Homo sapiens (Human) Osteosarcoma
SW1353 Homo sapiens (Human) Primary central chondrosarcoma
PC-3 Homo sapiens (Human) Prostate carcinoma
PC-3M Homo sapiens (Human) Prostate carcinoma
PC-3-AR Homo sapiens (Human) Prostate carcinoma
PPC-1 Homo sapiens (Human) Prostate carcinoma
MDA-PCa-2b Homo sapiens (Human) Prostate carcinoma
RMS13 Mus musculus (Mouse) Mouse rhabdomyosarcoma
UMR-106 Rattus norvegicus (Rat) Rat osteosarcoma
ROS 17/2.8 Rattus norvegicus (Rat) Rat osteosarcoma
MC3T3-E1 Mus musculus (Mouse) -